India has helped push China back as its generous gesture of donating the indigenously done Astra Zeneca Covid-19 vaccine is getting praises from its South Asian patrons.  India has sent off a supply manufactured by the Serum Institute of India. Supplies have started to be sent to the Maldives, Bhutan, Bangladesh, and Nepal. Myanmar and ...

India has already rolled out vaccines on January 16 for its population, who are receiving one of the two indigenous vaccines – Covishield or Covaxin. Now in an attempt to do its bit for vaccine diplomacy and equitable distribution of Covid-19 vaccine, India is supplying the first lot of its vaccines to neighboring and key ...

Indian Vaccine Export: Black marketing of the Covid-19 vaccine might not trouble India after all. Recent reports confirm that the Indian vaccine maker Serum Institute CEO Adar Poonawalla has been strictly told that the Indian government approved Astra Zeneca Oxford vaccine will not be available into the private market for several months, after it is released ...

Oxford vaccine: India has moved one step closer to getting its Covid-19 vaccine rollout approved as the expert panel has cleared use of Covishield, the Oxford-AstraZeneca vaccine being developed by Pune based Serum Institute of India. On Friday, the expert panel at DCGI (Drugs Controller General of India) gave its recommendation for EUA (emergency use ...

Covid Vaccine By Christmas Time: India might have a vaccine available by Christmas time, provided the UK medicine drug regulator MHRA approves it. Locally developed in India by the Serum Institute of India (SII), the drug is called Covishied.  With this, SII would be able to secure an emergency approval from the related agencies in ...

SII & Bharat Biotech: India’s hopes of getting Covid-19 vaccines in a matter of days flickered away – India might have to wait just a bit longer to get a country-made vaccine rolled out for the coronavirus. Drug Controller General of India (DCGI) has put the Covid-19 vaccines Covishield and Covaxin on hold for emergency ...

First logistics blueprints: After Pfizer and Serum Institute of India approached India’s medical regulatory body DCGI seeking approval for their vaccine against Covid-19, Hyderabad-based Bharat Biotech too approached the body on Monday for approval of India’s first indigenous Covid-19 vaccine, Covaxin. Citing the progress country is making in manufacturing and procuring Covid-19 vaccine, high level ...

Serum Institute of India:  On Sunday, Serum Institute of India became the first indigenous pharma firm to apply for emergency use of Covishield, the Covid-19 vaccine. SII applied to DCGI (Drugs Controller General of India), India’s drug regulator, seeking authorization for Oxford vaccine’s emergency use in India. This comes a day after DCGI approved emergency ...

Serosurvey: By Friday morning India had crossed 93 lakh mark of Covid-19 cases and added 43,082 new cases in 24 hours. Death tally reached 1,35,715 with 492 new fatalities being added. Recovered patients have reached 87.18 lakh tally.  ICMR (Indian Council of Medical Research) conducted a second national serosurvey that shows over 70% of Indian ...

Oxford vaccine: By late January or early February, India is most likely to get the first lot of Covid-19 vaccines that will be used for frontline workers, including healthcare personnel and municipal staff. The Oxford-AstraZeneca vaccine’s availability will be possible as the Pune based Serum Institute of India is to get the approval for vaccine’s ...